A protein signature associated with active tuberculosis identified by plasma profiling and network-based analysis.

clinical finding disease infectious disease proteomics

Journal

iScience
ISSN: 2589-0042
Titre abrégé: iScience
Pays: United States
ID NLM: 101724038

Informations de publication

Date de publication:
22 Dec 2022
Historique:
received: 09 05 2022
revised: 19 09 2022
accepted: 18 11 2022
entrez: 23 12 2022
pubmed: 24 12 2022
medline: 24 12 2022
Statut: epublish

Résumé

Annually, approximately 10 million people are diagnosed with active tuberculosis (TB), and 1.4 million die of the disease. If left untreated, each person with active TB will infect 10-15 new individuals. The lack of non-sputum-based diagnostic tests leads to delayed diagnoses of active pulmonary TB cases, contributing to continued disease transmission. In this exploratory study, we aimed to identify biomarkers associated with active TB. We assessed the plasma levels of 92 proteins associated with inflammation in individuals with active TB (n = 20), latent TB (n = 14), or healthy controls (n = 10). Using co-expression network analysis, we identified one module of proteins with strong association with active TB. We removed proteins from the module that had low abundance or were associated with non-TB diseases in published transcriptomic datasets, resulting in a 12-protein plasma signature that was highly enriched in individuals with pulmonary and extrapulmonary TB and was further associated with disease severity.

Identifiants

pubmed: 36561889
doi: 10.1016/j.isci.2022.105652
pii: S2589-0042(22)01924-1
pmc: PMC9763869
doi:

Types de publication

Journal Article

Langues

eng

Pagination

105652

Informations de copyright

© 2022 The Author(s).

Déclaration de conflit d'intérêts

The authors declare no competing interests.

Références

Sci Transl Med. 2019 Oct 23;11(515):
pubmed: 31645455
J Clin Microbiol. 2021 Nov 18;59(12):e0137021
pubmed: 34550805
Front Immunol. 2021 Feb 26;12:607827
pubmed: 33717089
Semin Immunol. 2014 Dec;26(6):552-8
pubmed: 25444549
Biosci Rep. 2018 Jun 12;38(3):
pubmed: 29555826
Front Microbiol. 2018 Jun 13;9:1267
pubmed: 29951049
Br J Cancer. 2022 Jun;126(12):1663-1675
pubmed: 35228677
Clin Transl Immunology. 2021 Jun 22;10(6):e1298
pubmed: 34188917
Lancet Respir Med. 2020 Jun;8(6):585-596
pubmed: 32526187
PLoS One. 2014 Apr 22;9(4):e95192
pubmed: 24755770
Front Immunol. 2021 Feb 04;11:626049
pubmed: 33613569
J Clin Invest. 2011 May;121(5):1827-33
pubmed: 21519144
Int J Infect Dis. 2017 Mar;56:258-262
pubmed: 27836792
BMC Infect Dis. 2021 Jan 22;21(1):106
pubmed: 33482742
JCI Insight. 2020 Sep 17;5(18):
pubmed: 32780727
Mol Med Rep. 2018 Aug;18(2):1551-1559
pubmed: 29901122
BMC Bioinformatics. 2021 Jun 29;22(1):352
pubmed: 34187355
BMC Med. 2016 Mar 23;14:37
pubmed: 27005907
Annu Rev Immunol. 2013;31:475-527
pubmed: 23516984
Thorax. 2016 Sep;71(9):785-94
pubmed: 27146200
Cochrane Database Syst Rev. 2019 Jun 07;6:CD009593
pubmed: 31173647
PLoS One. 2011;6(10):e26938
pubmed: 22046420
J Infect. 2019 Apr;78(4):281-291
pubmed: 30528869
PLoS Comput Biol. 2008 Nov;4(11):e1000217
pubmed: 18989396
J Infect Dis. 2013 Nov 15;208(10):1664-8
pubmed: 23901082
J Clin Microbiol. 2017 Feb;55(2):391-402
pubmed: 27852671
Tuberculosis (Edinb). 2016 Jul;99:56-62
pubmed: 27450006
Clin Infect Dis. 2020 Feb 14;70(5):731-737
pubmed: 30919880
PLoS Med. 2013 Oct;10(10):e1001538
pubmed: 24167453
Front Immunol. 2021 Feb 25;12:639174
pubmed: 33717190
Nat Microbiol. 2019 May;4(5):748-758
pubmed: 30804546
Open Forum Infect Dis. 2019 May 31;6(7):ofz257
pubmed: 31281858
Nature. 2010 Aug 19;466(7309):973-7
pubmed: 20725040
Nat Commun. 2018 Jun 19;9(1):2308
pubmed: 29921861
Proc Natl Acad Sci U S A. 2012 May 15;109(20):7853-8
pubmed: 22547807
Nature. 2018 Aug;560(7720):644-648
pubmed: 30135583
Sci Rep. 2020 Mar 2;10(1):3844
pubmed: 32123229
J Immunol. 2008 Jul 1;181(1):116-25
pubmed: 18566376
JCI Insight. 2016 Oct 06;1(16):e87238
pubmed: 27734027
Biochem Biophys Res Commun. 2018 Sep 18;503(4):2263-2270
pubmed: 29959917
Am J Respir Crit Care Med. 2018 May 1;197(9):1198-1208
pubmed: 29624071
Tuberculosis (Edinb). 2018 Mar;109:41-51
pubmed: 29559120
Nucleic Acids Res. 2015 Apr 20;43(7):e47
pubmed: 25605792
BMC Res Notes. 2009 Feb 04;2:19
pubmed: 19193208
BMC Pulm Med. 2017 Dec 13;17(1):202
pubmed: 29237451
J Clin Microbiol. 2017 Oct;55(10):3057-3071
pubmed: 28794177
Front Microbiol. 2021 Jun 14;12:650567
pubmed: 34194403
Front Immunol. 2021 Mar 02;12:637164
pubmed: 33763081
Bioinformatics. 2014 Oct;30(19):2811-2
pubmed: 24930139
PLoS One. 2017 Nov 2;12(11):e0187313
pubmed: 29095918
Tuberculosis (Edinb). 2017 Dec;107:48-58
pubmed: 29050771
Cell. 2016 Apr 21;165(3):535-50
pubmed: 27104977
Cell Rep. 2019 May 14;27(7):2119-2131.e6
pubmed: 31091450
Biomed Mater Eng. 2015;26 Suppl 1:S1837-43
pubmed: 26405955
J Mol Med (Berl). 2007 Jun;85(6):613-21
pubmed: 17318616
Bioinformatics. 2016 Sep 15;32(18):2847-9
pubmed: 27207943
Genome Res. 2003 Nov;13(11):2498-504
pubmed: 14597658
EBioMedicine. 2015 Jul 30;2(9):1160-8
pubmed: 26501113
Front Immunol. 2020 Jul 14;11:1470
pubmed: 32760401
J Infect Dis. 2007 Jan 1;195(1):46-54
pubmed: 17152008
Front Immunol. 2021 Apr 01;12:641065
pubmed: 33868272
EMBO Mol Med. 2015 Dec 18;8(2):86-95
pubmed: 26682570
Lancet Infect Dis. 2021 Mar;21(3):366-375
pubmed: 33508221
Tuberculosis (Edinb). 2011 May;91(3):260-7
pubmed: 21459676
Trends Mol Med. 2007 May;13(5):175-82
pubmed: 17418641
Lancet Infect Dis. 2006 Sep;6(9):570-81
pubmed: 16931408
Front Microbiol. 2022 Apr 26;13:845229
pubmed: 35558124
Crit Care. 2012 Aug 16;16(4):R157
pubmed: 22898401
PLoS One. 2013 Aug 05;8(8):e70630
pubmed: 23940611
Int J Tuberc Lung Dis. 2019 Nov 1;23(11):1155-1161
pubmed: 31718751
Front Immunol. 2021 Oct 07;12:725447
pubmed: 34691031
J Infect Dis. 2015 Nov 1;212(9):1469-79
pubmed: 25895988
BMC Bioinformatics. 2013 Jan 16;14:7
pubmed: 23323831
Eur Respir J. 2016 Jun;47(6):1873-6
pubmed: 27076596
J Clin Microbiol. 2016 Feb;54(2):274-82
pubmed: 26582831
Sci Adv. 2022 Aug 19;8(33):eabm5164
pubmed: 35984888
Int J Tuberc Lung Dis. 2015 May;19(5):504-16
pubmed: 25868017
PLoS Pathog. 2017 Jun 5;13(6):e1006425
pubmed: 28582466
BMC Bioinformatics. 2016 Jan 11;17 Suppl 1:3
pubmed: 26818387
J Cell Mol Med. 2020 Mar;24(5):2866-2878
pubmed: 32048448
Cochrane Database Syst Rev. 2021 Feb 22;2:CD009593
pubmed: 33616229
Eur Respir J. 2011 Aug;38(2):456-64
pubmed: 21659415
Lancet Respir Med. 2016 Mar;4(3):213-24
pubmed: 26907218
PLoS One. 2016 Oct 5;11(10):e0162220
pubmed: 27706152
BMC Bioinformatics. 2008 Dec 29;9:559
pubmed: 19114008
Proc Natl Acad Sci U S A. 2017 Aug 15;114(33):E6912-E6921
pubmed: 28760953
Lancet. 2006 Sep 16;368(9540):1012-21
pubmed: 16980117
Sci Rep. 2016 Jan 04;6:18520
pubmed: 26725873
Proc Natl Acad Sci U S A. 2015 Feb 10;112(6):1827-32
pubmed: 25624495
Sci Rep. 2020 Jun 24;10(1):10258
pubmed: 32581224
Tuberculosis (Edinb). 2015 Jul;95(4):421-5
pubmed: 26025597
Microbiol Spectr. 2016 Oct;4(5):
pubmed: 27763258
Lancet Respir Med. 2020 Jun;8(6):531-533
pubmed: 32526184
J Immunol. 1998 Feb 15;160(4):1701-7
pubmed: 9469427
Sci Rep. 2019 Dec 3;9(1):18217
pubmed: 31796883
Proteomics. 2015 Jan;15(1):58-67
pubmed: 25332062
J Proteome Res. 2021 Jan 1;20(1):751-762
pubmed: 33253581
Sci Rep. 2016 Dec 07;6:38362
pubmed: 27924827
J Infect Dis. 2015 Jul 15;212(2):213-22
pubmed: 25637350
Infect Immun. 2000 May;68(5):3002-6
pubmed: 10769003
Nucleic Acids Res. 2013 Oct;41(18):e170
pubmed: 23921631
Eur Respir J. 2019 Sep 12;54(3):
pubmed: 31221810

Auteurs

Zaynab Mousavian (Z)

Division of Infectious Diseases, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.
School of Mathematics, Statistics and Computer Science, College of Science, University of Tehran, Tehran, Iran.

Elin Folkesson (E)

Division of Infectious Diseases, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden.

Gabrielle Fröberg (G)

Division of Infectious Diseases, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
Department of Clinical Microbiology, Karolinska University Laboratory, Karolinska University Hospital, Stockholm, Sweden.

Fariba Foroogh (F)

Division of Infectious Diseases, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.
Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden.

Margarida Correia-Neves (M)

Division of Infectious Diseases, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
Life and Health Sciences Research Institute, School of Medicine, University of Minho, Braga, Portugal.
ICVS/3B's, PT Government Associate Laboratory, Braga, Portugal.

Judith Bruchfeld (J)

Division of Infectious Diseases, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden.

Gunilla Källenius (G)

Division of Infectious Diseases, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.
Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden.

Christopher Sundling (C)

Division of Infectious Diseases, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.
Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden.

Classifications MeSH